Study of Clinical Profile and In-Hospital Outcomes of Patients Undergoing Percutaneous Transvenous Mitral Commissurotomy

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is the preferred treatment for patients with symptomatic severe rheumatic mitral stenosis and favorable valve morphology. It replicates the physiological mechanism of surgical commissurotomy with less invasiveness. Objective: This study aimed to assess the clinical profile and in-hospital outcomes of patients undergoing PTMC at a tertiary cardiac care center. Methods: A prospective observational study was conducted at the Armed Forces Institute of Cardiology, Rawalpindi, from July 1 to December 31, 2023. A total of 96 patients with severe rheumatic mitral stenosis who met the eligibility criteria underwent PTMC. Baseline demographic, clinical, and echocardiographic data were recorded. Pre- and post-procedural mitral valve area (MVA), mean transmitral gradient, and pulmonary artery systolic pressure (PASP) were assessed. Procedural success and in-hospital complications were documented. Data were analyzed using SPSS version 26.0, with p-values <0.05 considered significant. Results: The mean age of the study population was 38.6 ± 10.4 years, with a female predominance (78.1%). Most patients (68.8%) presented in NYHA Class III. Mean MVA increased significantly from 0.89 ± 0.12 cm² to 1.85 ± 0.21 cm² (p < 0.001). Mean transmitral gradient reduced from 17.4 ± 4.3 mmHg to 6.9 ± 2.1 mmHg (p < 0.001), and PASP decreased from 58.6 ± 13.2 mmHg to 39.5 ± 9.4 mmHg (p < 0.001). Procedural success was achieved in 92.7% of patients. Mild and moderate mitral regurgitation developed in 18.8% and 4.2% of cases, respectively. Complications included cardiac tamponade (2.1%) and vascular hematoma (3.1%). There was no in-hospital mortality. Conclusion: PTMC is a safe and effective intervention for severe rheumatic mitral stenosis, resulting in significant hemodynamic and symptomatic improvement with minimal complications. Proper patient selection and procedural expertise are key to successful outcomes.

Authors

Institutions

Publication Details

Journal
Biological and Clinical Sciences Research Journal
Published
2025-05-31
DOI
https://doi.org/10.54112/bcsrj.v6i5.1753
Citations
1
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of Clinical Profile and In-Hospital Outcomes of Patients Undergoing Percutaneous Transvenous Mitral Commissurotomy

Hassan Shabeer
1 citations
Biological and Clinical Sciences Research Journal
Cardiac pacing and defibrillation studies
1.39
article

Study of Clinical Profile and In-Hospital Outcomes of Patients Undergoing Percutaneous Transvenous Mitral Commissurotomy

Hassan Shabeer
article en
1 citations

Abstract

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is the preferred treatment for patients with symptomatic severe rheumatic mitral stenosis and favorable valve morphology. It replicates the physiological mechanism of surgical commissurotomy with less invasiveness. Objective: This study aimed to assess the clinical profile and in-hospital outcomes of patients undergoing PTMC at a tertiary cardiac care center. Methods: A prospective observational study was conducted at the Armed Forces Institute of Cardiology, Rawalpindi, from July 1 to December 31, 2023. A total of 96 patients with severe rheumatic mitral stenosis who met the eligibility criteria underwent PTMC. Baseline demographic, clinical, and echocardiographic data were recorded. Pre- and post-procedural mitral valve area (MVA), mean transmitral gradient, and pulmonary artery systolic pressure (PASP) were assessed. Procedural success and in-hospital complications were documented. Data were analyzed using SPSS version 26.0, with p-values <0.05 considered significant. Results: The mean age of the study population was 38.6 ± 10.4 years, with a female predominance (78.1%). Most patients (68.8%) presented in NYHA Class III. Mean MVA increased significantly from 0.89 ± 0.12 cm² to 1.85 ± 0.21 cm² (p < 0.001). Mean transmitral gradient reduced from 17.4 ± 4.3 mmHg to 6.9 ± 2.1 mmHg (p < 0.001), and PASP decreased from 58.6 ± 13.2 mmHg to 39.5 ± 9.4 mmHg (p < 0.001). Procedural success was achieved in 92.7% of patients. Mild and moderate mitral regurgitation developed in 18.8% and 4.2% of cases, respectively. Complications included cardiac tamponade (2.1%) and vascular hematoma (3.1%). There was no in-hospital mortality. Conclusion: PTMC is a safe and effective intervention for severe rheumatic mitral stenosis, resulting in significant hemodynamic and symptomatic improvement with minimal complications. Proper patient selection and procedural expertise are key to successful outcomes.

Biological and Clinical Sciences Research JournalVol. 6(5)
Armed Forces Institute of Pathology (PK)
Openalex Percentile: Top 18%
Cardiac pacing and defibrillation studies
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Study of Clinical Profile and In-Hospital Outcomes of Patients Undergoing Percutaneous Transvenous Mitral Commissurotomy — Hassan Shabeer · Biological and Clinical Sciences Research Journal (2025) | TGRS Research Map | TGRS